Re-appearance of hepatitis B virus following therapy with rituximab for lymphoma is not rare in Japanese patients with past hepatitis B virus infection
Masaaki Watanabe(Kitasato University), Wasaburo Koizumi(Kitasato University), Mikio Danbara(Kitasato University), Takahide Nakazawa(Kitasato University Hospital), Tsutomu Minamino(Kitasato University), Akitaka Shibuya, Ryouichi Horie(Kanagawa Institute of Technology), Juichi Takada(Kitasato University), Yuhko Tsunoda(Kitasato University), Manabu Ohsaka(Kitasato University), Ryuji Ishii(Kitasato University), Yusuke Okuwaki(Kitasato University), Hisashi Hidaka(Kitasato University), Masaaki Higashihara(Kitasato University), Yoshiaki Tanaka(Jichi Medical University)
Cited by 22
Related Papers
Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells.
|Journal of Biological Chemistry|1990|1.5k
KN-62, 1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazi ne, a specific inhibitor of Ca2+/calmodulin-dependent protein kinase II.
|Journal of Biological Chemistry|1990|625
N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide, a calmodulin antagonist, inhibits cell proliferation.
|Proceedings of the National Academy of Sciences|1981|586
Selective inhibition of catalytic activity of smooth muscle myosin light chain kinase.
|Journal of Biological Chemistry|1987|513
MAPKAP kinase‐2; a novel protein kinase activated by mitogen‐activated protein kinase.
|The EMBO Journal|1992|481